Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Kouichi Fukunaga"'
Autor:
Takao Mochimaru, Hiroki Kabata, Shinichi Okuzumi, Soichiro Ueda, Kouichi Fukunaga, Rie Baba, Takae Tanosaki, M. Kuwae, Yusuke Suzuki, Risa Watanabe, Masako Matsusaka, Koichiro Asano, Takashi Kamatani
Publikováno v:
B37. NOVEL APPROACHES TO ASTHMA MANAGEMENT AND OUTCOMES.
Autor:
M. Kuwae, Yumiko Tanaka, Yoshitaka Shirasaki, Y. Araki, Masako Matsusaka, T. Kikawada, S. Koga, Kouichi Fukunaga, S. Moro, Mai Yamagishi, K. Moro, Takashi Kamatani, Kaede Miyata
Publikováno v:
B32. ASTHMA: MECHANISMS OF DISEASE I.
Autor:
Takae Tanosaki, Koichiro Asano, Yusuke Suzuki, Soichiro Ueda, Takao Mochimaru, Katsunori Masaki, Risa Watanabe, M. Nishiura, Masako Matsusaka, Kouichi Fukunaga, Jun Miyata, M. Kuwae, Shinichi Okuzumi
Publikováno v:
A32. ASTHMA: CLINICAL STUDIES II.
Autor:
Kouichi Fukunaga, Jun Miyata, M. Nishiura, Takae Tanosaki, M. Kuwae, Soichiro Ueda, Shinichi Okuzumi, Risa Watanabe, Shizuko Kagawa, Masako Matsusaka, Takao Mochimaru
Publikováno v:
B32. ASTHMA: MECHANISMS OF DISEASE I.
Publikováno v:
Asian Pacific Journal of Disease Management. 7:35-43
Autor:
Katsuhiko Naoki, Kyoko Niimi, Yusuke Suzuki, Yoshiki Shiraishi, Kazuhiro Yamaguchi, Tetsuya Shiomi, T. Nakajima, Kouichi Fukunaga, Nagato Satoh, Koichiro Asano, Tsuyoshi Oguma, Akitoshi Ishizaka
Publikováno v:
Biochemical and Biophysical Research Communications. 317:205-210
Approximately 4% of the Japanese population genetically lack plasma platelet activating factor acetylhydrolase (PAF-AH) and show a higher prevalence of thromboembolic disease, but whether they are susceptible to another PAF-related disease, asthma, r
Autor:
Kathleen J. Haley, Kazuhiro Yamaguchi, Morio Nakamura, Tsuyoshi Oguma, Tetsuya Shiomi, Jeffrey M. Drazen, Craig M. Lilly, K. Asano, Kouichi Fukunaga, Hiroaki Matsubara, Yusuke Suzuki, Holly K. Sheldon
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 165:382-386
Prostaglandins and thromboxanes are important modulators of airway physiology. The synthesis of these mediators depends on two isoforms of cyclooxygenase (COX), constitutive COX-1 and inducible COX-2. COX-2 expression has been observed in various inf
Autor:
Shinichiro Okamoto, Koichiro Asano, Makiko Iwata, Kouichi Fukunaga, Kazuhiro Yamaguchi, Yasuo Ikeda, Takehiko Mori, Tetsuya Shiomi
Publikováno v:
Biochemical and Biophysical Research Communications. 261:511-514
Platelet activating factor (PAF) is immediately degraded and inactivated in the bloodstream by plasma PAF acetylhydrolase (PAF-AH). Although plasma PAF-AH-like activity was secreted in vitro from various cell types such as macrophages and hepatocytes
Autor:
Makiko Iwata, Nagato Satoh, Kazuhiro Yamaguchi, Minoru Kanazawa, Koichiro Asano, Katsuhiko Naoki, Kouichi Fukunaga
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 159:974-979
Platelet-activating factor (PAF), a phospholipid with a wide range of proinflammatory actions, is immediately degraded and inactivated in vivo by PAF acetylhydrolase (PAF-AH). Surprisingly, 4% of the Japanese population lacks the extracellular isofor
Autor:
Hidetoshi Nakamura, Koichiro Asano, Naoki Hasegawa, Hiroyasu Kudo, Kouichi Fukunaga, Haruhiko Hakuno, Tatsu Matsuzaki, Tetsuya Shiomi, Yusuke Suzuki, Kazuhiro Yamaguchi, Minoru Kanazawa
Publikováno v:
Pharmacogenetics. 12(7)
CysLT(1) antagonists are effective for a subset of patients with asthma; however, there has been no good way to predict a given patient's response. We examined the interaction between the clinical response to a cysLT(1) antagonist, pranlukast, and DN